The Kinetix Group: Leading the Life Sciences to Success
The U.S. healthcare industry is experiencing a dramatic shift toward value-based care due to the IHI's Quadruple Aim approach to care delivery. This shift requires that healthcare stakeholders, especially those in the market-access channel, move away from traditional approaches and develop and execute new strategies. Given that new formulary influencers have emerged within traditional customer channels alongside multiple stakeholder partnerships to promote the Quadruple Aim, it is imperative that market-access teams identify and engage these individuals in innovative ways.
TKG's decisive position:
The healthcare industry's expanding network of formulary influencers has led to exciting partnership opportunities among stakeholders, with TKG's paving the way for collaboration. As a unique blend of both life-sciences marketing agency and health system and payer consultancy, TKG is at the front line of care delivery and has a direct line of sight into areas of opportunity for industry leaders to collaborate with their market-access customers in innovative ways. One such partnership that demonstrates TKG's leadership in bridging the gap between managed markets is its work with the American Medical Group Association (AMGA), the country's leading medical trade association, which represents more than 400 medical groups, health systems, and other organized systems of care.
Putting the patient back at the center of care delivery:
Through its existing partnership with AMGA and many of its member organizations, TKG identified a need for initiatives focused on improving outcomes in specialty care, including the identification, referral, and ongoing management of patients impacted by such immunologic diseases as rheumatoid arthritis (RA). As such, the “Best Practices in Managing Patients with Rheumatoid Arthritis (RA Collaborative)” began in 2015 and included 18 member organizations of AMGA, representing both health systems and integrated delivery networks (health system and health plan mergers). Over a 12-month period, the participating groups reached close to 100,000 patients with RA and identified areas of best practice patient management, including early identification and appropriate and timely referral.
Bearing the future in mind:
“TKG is proud to partner with AMGA to improve RA care delivery as well as build future collaboratives for other pressing chronic conditions.”
— John Strapp Jr., chairman of The Kinetix Group
The RA Collaborative concluded with widespread enthusiasm and a sense of renewed momentum among its AMGA participants. Each rheumatology group developed its own best-practice case study, highlighting the positive results of the pilot. AMGA released a complete compendium of best-practice case studies from the RA Collaborative, available to the public as an educational resource for practices looking to improve RA care.
With much work left to be done in improving market access through practice transformation, AMGA and TKG have since expanded and strengthened their partnership. The organizations are developing a new collaborative to address market access needs in heart failure care, with plans for a similar pilot program in the works.
TKG has demonstrated its wide breadth of expertise in many other market-access case studies. TKG understands the key drivers in the evolving healthcare landscape and acts as a strategic partner in the development of resources enabling all market-access stakeholders to improve the delivery of healthcare and the health of patients.